Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp ; volume:15 ; number:1 ; day:14 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
Nature Communications ; 15, Heft 1 (14.10.2024), 1-10, 12.2024
- Urheber
-
Rodrigues, Manuel
Ramtohul, Toulsie
Rampanou, Aurore
Sandoval, José Luis
Houy, Alexandre
Servois, Vincent
Mailly-Giacchetti, Léah
Pierron, Gaelle
Vincent-Salomon, Anne
Cassoux, Nathalie
Mariani, Pascale
Dutriaux, Caroline
Pracht, Marc
Ryckewaert, Thomas
Kurtz, Jean-Emmanuel
Roman-Roman, Sergio
Piperno-Neumann, Sophie
Bidard, François-Clément
Stern, Marc-Henri
Renault, Shufang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-53145-0
- URN
-
urn:nbn:de:101:1-2501012102373.234199984179
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rodrigues, Manuel
- Ramtohul, Toulsie
- Rampanou, Aurore
- Sandoval, José Luis
- Houy, Alexandre
- Servois, Vincent
- Mailly-Giacchetti, Léah
- Pierron, Gaelle
- Vincent-Salomon, Anne
- Cassoux, Nathalie
- Mariani, Pascale
- Dutriaux, Caroline
- Pracht, Marc
- Ryckewaert, Thomas
- Kurtz, Jean-Emmanuel
- Roman-Roman, Sergio
- Piperno-Neumann, Sophie
- Bidard, François-Clément
- Stern, Marc-Henri
- Renault, Shufang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel treatment paradigms for metastatic uveal melanoma
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Detection of metastases using circulating tumour DNA in uveal melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Novel treatment paradigms for metastatic uveal melanoma
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Detection of metastases using circulating tumour DNA in uveal melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Novel treatment paradigms for metastatic uveal melanoma
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Detection of metastases using circulating tumour DNA in uveal melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma